|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-1-18
|
|
pubmed:abstractText |
Results of experimental and clinical studies suggest that recombinant human interleukin 1 receptor antagonist (rhIL1ra) may be a good new therapeutic agent for acute stroke. In humans, IL1ra is encoded by the IL1RN gene located on chromosome 2.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-10695731,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-10814801,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-11073843,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-11466424,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-12686792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-1445301,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-15036607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-15184294,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-15727272,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-15879341,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-15961713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-16170078,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-16410468,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-3363586,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-3363593,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-3901425,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-7678184,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-7851026,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-9059733,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16980335-9596247
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1468-330X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
183-6
|
|
pubmed:dateRevised |
2010-9-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16980335-Brain Ischemia,
pubmed-meshheading:16980335-Cohort Studies,
pubmed-meshheading:16980335-Genotype,
pubmed-meshheading:16980335-Humans,
pubmed-meshheading:16980335-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:16980335-Minisatellite Repeats,
pubmed-meshheading:16980335-Polymorphism, Genetic,
pubmed-meshheading:16980335-Prognosis,
pubmed-meshheading:16980335-Stroke,
pubmed-meshheading:16980335-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
IL1RN intron 2 polymorphism caused by variable number tandem repeats is associated with 1-year outcome in patients with ischaemic stroke.
|
|
pubmed:affiliation |
Institute of Psychiatry and Neurology; 2-Medical University, Warsaw, Poland. gromadz@ipin.edu.pl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
